Raab & Moskowitz Asset Management LLC Amgen Inc Transaction History

Raab & Moskowitz Asset Management LLC

$405 Million
Q4 2024

A detailed history of Raab & Moskowitz Asset Management LLC transactions in Amgen Inc stock. As of the latest transaction made, Raab & Moskowitz Asset Management LLC holds 815 shares of AMGN stock, worth $239,235. This represents 0.05% of its overall portfolio holdings.

Number of Shares

815

Previous 907 10.14%

Holding current value

$239,235

Previous $292,000 27.4%

% of portfolio

0.05%

Previous 0.07%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Jan 29, 2025	SELL	$258.78 - $328.31 $23,807 - $30,204	-92 Reduced 10.14%	815 $212,000
Q3 2024 Nov 15, 2024	SELL	$309.38 - $337.38 $5,259 - $5,735	-17 Reduced 1.84%	907 $292,000
Q2 2024 Aug 15, 2024	BUY	$262.75 - $319.31 $26,537 - $32,250	101 Added 12.27%	924 $288,000
Q1 2024 May 14, 2024	BUY	$268.87 - $324.56 $13,443 - $16,228	50 Added 6.47%	823 $233,000
Q4 2023 Feb 02, 2024	SELL	$255.7 - $288.46 $34,775 - $39,230	-136 Reduced 14.96%	773 $222,000
Q3 2023 Oct 30, 2023	BUY	$218.65 - $271.46 $198,752 - $246,757	909 New	909 $244,000
Q1 2023 May 15, 2023	SELL	$225.79 - $275.2 $5,644 - $6,880	-25 Reduced 2.83%	858 $207,000
Q4 2022 Jan 27, 2023	BUY	$229.03 - $291.01 $202,233 - $256,961	883 New	883 $0
Q2 2022 Aug 15, 2022	BUY	$230.71 - $256.74 $4,614 - $5,134	20 Added 2.25%	908 $220,000
Q4 2021 Feb 07, 2022	BUY	$198.88 - $227.6 $176,605 - $202,108	888 New	888 $200,000
Q3 2021 Nov 03, 2021	SELL	$212.27 - $248.7 $198,047 - $232,037	-933 Closed	0 $0
Q4 2020 Feb 12, 2021	BUY	$216.38 - $257.67 $4,327 - $5,153	20 Added 2.19%	933 $214,000
Q3 2020 Nov 13, 2020	SELL	$234.65 - $260.95 $18,772 - $20,876	-80 Reduced 8.06%	913 $232,000
Q2 2020 Aug 13, 2020	BUY	$197.81 - $242.74 $395 - $485	2 Added 0.2%	993 $234,000
Q1 2020 May 14, 2020	SELL	$182.24 - $241.7 $1,275 - $1,691	-7 Reduced 0.7%	991 $200,000
Q4 2019 Feb 10, 2020	BUY	$189.21 - $243.2 $188,831 - $242,713	998 New	998 $240,000
Q3 2019 Nov 13, 2019	SELL	$174.11 - $208.62 $196,047 - $234,906	-1,126 Closed	0 $0
Q2 2019 Aug 09, 2019	BUY	$166.7 - $195.41 $187,704 - $220,031	1,126 New	1,126 $207,000
Q1 2019 May 13, 2019	SELL	$180.87 - $203.88 $231,694 - $261,170	-1,281 Closed	0 $0
Q4 2018 Feb 04, 2019	BUY	$178.4 - $208.25 $140,400 - $163,892	787 Added 159.31%	1,281 $249,000
Q3 2018 Nov 14, 2018	BUY	$185.29 - $208.89 $91,533 - $103,191	494 New	494 $102,000

Others Institutions Holding AMGN

# of Institutions

3,095

Shares Held

405M

Call Options Held

7.57M

Put Options Held

7.12M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $157B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Raab & Moskowitz Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Raab & Moskowitz Asset Management LLC with notifications on news.

Account

Raab & Moskowitz Asset Management LLC Amgen Inc Transaction History